Last updated on September 2018

Evaluation of ALD403 (Eptinezumab) in the Prevention of Chronic Migraine

Brief description of study

The purpose of this study is to assess the efficacy and safety of ALD403 in the prevention of migraine headache in chronic migraineurs.

Clinical Study Identifier: NCT02974153

Contact Investigators or Research Sites near you

Start Over

Alder Study Registration Call Center

Research Site
Champaign, IL United States